جست‌وجوی استاد و پژوهشگر

• Cardiology
• Cardiovascular Medicine
• Heart Disease
• +۳ مورد دیگر

Dr. Ahmed Mahrous Abouzaid is an Adjunct Professor affiliated with the School of Cardiovascular & Metabolic Health at the University of Glasgow . His research focuses on cardiovascular disease, particularly angina management, myocardial infarction pathophysiology, and clinical trial methodologies. He specializes in advanced diagnostic techniques like electrocardiography stress testing, cardiovascular magnetic resonance (CMR), and fractional flow reserve (FFR) analysis. His work emphasizes translating clinical research into improved patient outcomes, with a focus on non-obstructive coronary artery disease, left ventricular remodeling, and optimizing treatment strategies for non-ST elevation myocardial infarction (NSTEMI). He has contributed to high-impact studies published in journals such as European Heart Journal and Circulation . Recent research highlights include a 2024 randomized controlled trial evaluating invasive endotyping in angina patients and a 2025 study on electrocardiography stress testing for diagnostic accuracy. While no awards are explicitly listed, his publications reflect a strong commitment to advancing cardiovascular diagnostics and clinical practice. No grants or advising details are provided in the available text. His affiliation suggests active participation in collaborative research within the School's cardiovascular health initiatives.

• Cardiology
• Interventional Cardiology
• Coronary Artery Disease
• +۳ مورد دیگر

Elvin Kedhi, MD, PhD is an Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC) at the Glen site, where he is affiliated with the Cardiovascular Health Across the Lifespan Program. As a faculty member at McGill University's Faculty of Medicine, he contributes to both clinical practice and academic research in cardiology. Dr. Kedhi's research focuses on interventional cardiology, particularly coronary artery disease management, fractional flow reserve techniques, and clinical trials comparing different treatment approaches for cardiovascular conditions. His work often involves complex clinical scenarios including patients with diabetes, high bleeding risk, and multivessel coronary disease. He has pioneered research on thin-cap fibroatheroma identification and its clinical implications, as well as optimal dual antiplatelet therapy durations following stent implantation. His recent publications demonstrate a strong emphasis on comparing transcatheter and surgical approaches for treating patients with combined aortic valve stenosis and coronary artery disease. Dr. Kedhi frequently collaborates with international research teams across Europe and North America, contributing to large-scale multicenter clinical trials that shape current cardiovascular treatment guidelines. Active researcher in interventional cardiology clinical trials Focus on optimizing treatment strategies for complex coronary artery disease Expertise in fractional flow reserve and intravascular imaging techniques International collaborations across multiple continents Dr. Kedhi maintains an active clinical research program with numerous ongoing studies examining innovative approaches to cardiovascular disease management. His work bridges the gap between technological advances in cardiac interventions and practical clinical applications that improve patient outcomes.

Xin Zhouمشاهده پروفایل

پژوهشگر ارشد

• Computational Biology
• Health Informatics
• Cardiovascular Disease Modeling
• +۳ مورد دیگر

Dr. Xin Zhou is an Oxford-Bristol Myers Squibb Fellow at the Department of Computer Science, University of Oxford. Her research integrates computational modeling, clinical data, and experimental findings to investigate cardiac disease mechanisms and develop human-based simulations for drug evaluation. BSc and MSc in Life Sciences, Beijing Normal University DPhil in Computational Biology, University of Oxford Her work focuses on multi-scale cardiac modeling , particularly in ischemic heart disease and heart failure, exploring ionic currents, tissue conduction, and organ-level dynamics. She develops electromechanical simulations to study cardiac alternans and arrhythmic risks, translating these into clinical applications for patient stratification and pharmaceutical testing. Recent publications emphasize in silico clinical trials , sex-specific cardiometabolic analysis, and Purkinje network modeling. Collaborative efforts with clinicians and pharmaceutical partners highlight her translational approach to regulatory science. Model of the Year 2024, BioModels EPSRC Impact Acceleration Account Microsoft Research Project Award Recognition Award, University of Oxford She supervises PhD and MSc students in computational cardiology, while serving on the editorial board of Frontiers in Physiology . Her current projects involve digital twinning and predictive cardiac safety models to reduce animal testing reliance.

Virend Somersمشاهده پروفایل

استاد

• Cardiovascular Medicine
• Sleep Apnea
• Neurocirculatory Control
• +۹ مورد دیگر

Virend Somers, M.D., Ph.D. , is a Professor of Medicine at Mayo Clinic in Rochester, Minnesota, with primary appointments in the Department of Cardiovascular Medicine, and joint appointments in Physiology & Biomedical Engineering and Nephrology & Hypertension. He directs the Cardiovascular and Sleep Facilities within Mayo Clinic's Center for Clinical and Translational Science. Education: MB ChB, University of Natal D.Phil., University of Oxford Resident, Internal Medicine, University of Iowa Fellow, Cardiovascular Diseases, University of Iowa Hospitals and Clinics Research Interests: Dr. Somers' research centers on neural and vascular mechanisms in circulatory control, particularly in sleep disorders such as obstructive and central sleep apnea, hypertension, obesity, and heart failure. His team investigates autonomic nervous system regulation, chemoreflex responses, and vascular biology in humans. His work bridges basic physiology with clinical applications to improve cardiovascular outcomes. Publication Trends: His recent publications (2021–2025) show a strong emphasis on sleep-cardiovascular interactions, including blood pressure regulation during sleep, cardiovascular mortality in the context of comorbidities like obesity and COVID-19, and neurocardiological mechanisms in arrhythmias and syncope. His work frequently appears in high-impact journals such as Sleep , Journal of the American Heart Association , and Journal of Physiology . Scientific Awards: Alice Sheets Marriott Professor (2016) CTSA Mentor of the Year (2012) Distinguished Scientist in Cardiopulmonary Physiology, American College of Chest Physicians (2017) Stanford University World's Top 2% Scientists (2021) Lifetime Achievement Award, South African Society of Sleep Medicine (2012) Doctor Honoris Causa, Masaryk University (2007) Advising and Grants: Dr. Somers has mentored numerous trainees who have won national awards. His research is supported by four NIH R01 grants, a Dana Foundation grant, and a NATO grant. His leadership in collaborative research spans institutions in the U.S., Europe, and South Africa. Labs and Teams: He leads the Cardiovascular Facility and Sleep Facility at Mayo Clinic’s Center for Clinical and Translational Science, fostering interdisciplinary research on sleep and cardiovascular disease.

• Emergency Medicine
• Internal Medicine
• Cardiovascular Diseases
• +۳ مورد دیگر

Assoc. Prof. Dr. Levent ŞAHİN is a prominent academic in Emergency Medicine at Kafkas University's Faculty of Medicine. He holds a PhD in Internal Medical Sciences from İnönü University (2015) and an MD from Cumhuriyet University (2007). Currently serving as Head of the Department of Internal Medical Sciences (2022-) and Education Coordinator (2020-), his career spans 13 years of academic experience. Academic Affiliation: Kafkas University, Faculty of Medicine, Department of Internal Medical Sciences Previous Institutions: İnönü University (2011-2015) Research Pillars: Cardiovascular Emergencies (acute myocardial infarction biomarkers, cardiac trauma) Toxicology (organophosphate poisoning, drug-induced toxicity) Geriatric Medicine (diabetes-cholestasis relationships in elderly, climate/poisoning patterns) Pediatric Emergencies (head trauma assessment, spinal cord protection) Pandemic Medicine (N95 respirator effects, COVID-19 neurological complications) Medical Education (first aid training, textbook authorship) Publication Trends: Over 80 publications since 2019, with 15 recent works focusing on cardiovascular biomarkers (2024), neurological complications (2023), toxicology (2022), and pandemic-related clinical issues (2021). His experimental pharmacology research includes studies on hydrogen-rich saline and dragon fruit extract. Leadership: Department Head (2022-), Education Coordinator (2020-) Editorial Roles: Editor for Journal of Emergency Medicine Case Reports (2024), Taktik Sahada Acil Tıp (2024) Professional Memberships: ATUDER (2016-), TATD (2016-)

Craig Morrellمشاهده پروفایل

استاد

• Platelet Biology
• Vascular Inflammation
• Thrombosis
• +۵ مورد دیگر

Craig Morrell is a Professor at the University of Rochester School of Medicine and Dentistry , with joint appointments in the Departments of Medicine , Microbiology and Immunology , and Pathology and Laboratory Medicine . He serves as Associate Director of the Aab Cardiovascular Research Institute . Education: Sc.B. in Biology, Brown University (1995) D.V.M. , Tufts University School of Veterinary Medicine (2000) Ph.D. in Pathobiology, Johns Hopkins University (2005) His research examines the interface between platelets, vascular biology, and immune cells , focusing on platelet roles in thrombosis, inflammation, and immune regulation. Using advanced mouse models , his lab investigates platelet-derived mediators like β2M and PF4 in diseases such as malaria, stroke, and myocardial infarction. Article trends highlight platelets' dual roles in thrombosis and immune modulation , with recurring themes in vascular inflammation , ERK5 signaling , and age-related immune dysfunction . Scientific Awards: Kenneth M. Brinkous Young Investigators Prize (2008) Deans Gift research award (2006) Multiple travel scholarships and fellowships (2003-2005) Pathology Award-Excellence in Pathology (2000) Mentoring and Teaching : He has mentored 8 doctoral students , 7 undergraduates , and 6 postdoctoral fellows , with a focus on diversity. He serves on thesis committees and the URMC MSTP (MD/PhD) admissions committee . Labs and Collaborations : Leads the Morrell Lab at the Aab Cardiovascular Research Institute, collaborating with institutions like Johns Hopkins and Medical College of Wisconsin.

Chris Thiemermannمشاهده پروفایل

استاد

• Pathophysiology of shock (sepsis/trauma/ischaemia-reperfusion injury)
• Immuno-metabolic alterations in critical illness
• Organ dysfunction and protection mechanisms
• +۵ مورد دیگر

Professor Chris Thiemermann is a leading pharmacologist at Queen Mary University of London, serving as Centre Lead for Translational Medicine & Therapeutics at the William Harvey Research Institute since 2007. With 40 years of expertise in sepsis, traumatic shock, and ischaemia research, he co-leads the Organ Dysfunction and Protection Research Theme alongside Professor Karim Brohi, focusing on: Excessive inflammation and ischaemia in critical illness Gender-specific disease responses Aging-related tissue injury mechanisms Translatable interventions for organ protection Immuno-metabolic dysregulation in sepsis/diabetes/CKD His work bridges target discovery in animal models with clinical translation. As CEO of William Harvey Research Limited and trustee of multiple institutions, he maintains active academic and administrative roles. Current contact: c.thiemermann@qmul.ac.uk Scientific Recognition Academy of Medical Sciences Fellow Royal College of Physicians Fellow Foreign Fellow, Academia de Sciences de Lisboa

• Thrombosis
• Cardiovascular diseases
• Endothelial cell biology
• +۷ مورد دیگر

Associate Professor Freda Passam is a Clinical Academic Haematologist at Royal Prince Alfred Hospital, University of Sydney, specializing in thrombosis and haemostasis. She leads the Haematology Research Group at the Charles Perkins Centre, focusing on platelet biology, endothelial cell dysfunction, and translational research in cardiovascular diseases. Her work integrates basic science with clinical applications, including developing microfluidic technologies like the Endo-chip for thrombosis diagnosis and therapy screening. Education: MD and PhD in Greece (angiogenesis in Hodgkin’s lymphoma), postdoctoral training at UNSW and Harvard University. Research spans platelet hyperactivity in diabetes, immune thrombosis (e.g., HIT), and thiol isomerase inhibitors as antithrombotics. Collaborates globally with institutions like Harvard and the University of Utah. Research Interests: 1) Platelet biomarkers in diabetes-related cardiovascular risk; 2) Immune thrombosis diagnostics/therapies (e.g., Endo-chip); 3) Bone marrow-on-chip models for thrombopoiesis. Current projects include SEC61B regulation of calcium flux, endothelial thromboinflammation, and ERp5/ERp57 roles in platelet production. Grants: Over $6M in funding from NHMRC, MRFF, NSW Health, and industry partnerships. Notable awards include Sydney Nano Grand Challenge Award (2022) and SLHD VTE Stewardship Award (2020). Advising: Mentors over 6 PhD/master’s students in thrombosis research, emphasizing clinical/research integration. Teaching includes Sydney Medicine curriculum, bedside tutorials, and student engagement in lab activities. Labs/Teams: Haematology Research Group (Charles Perkins Centre), collaborations with Sydney Health Partners, Harvard, and international haematology groups. Develops technologies like the Endo-chip and bone marrow-on-chip models.

Anton Baysaمشاهده پروفایل

مدرس ارشد

• Cardiology
• Molecular Biology
• Cardiovascular Pathology
• +۵ مورد دیگر

Anton Baysa is a Senior Lecturer at the University of Oslo's Department of Pathology within the Faculty of Medicine. His research focuses on cardiovascular pathophysiology, particularly mechanisms of inflammation, mitochondrial dysfunction, and cellular repair following myocardial infarction and ischemia-reperfusion injury. He has published extensively on topics including Toll-like receptor signaling, mitochondrial DNA-induced inflammation, and the role of adaptor proteins in cardiac healing. His work integrates molecular biology, immunology, and clinical cardiology to understand and mitigate cardiac damage. Collaborative projects include studies on extracellular vesicles in surgery-related complications and growth factor pathways in myocardial repair. Key Research Themes: Cardiac inflammation mechanisms, mitochondrial damage responses, post-infarction healing, oxidative stress mitigation Recent Projects: Investigating p66ShcA protein signaling, nucleolin inhibition effects, and BMP-mediated cardiac remodeling

Vernon Chinchilliمشاهده پروفایل

استاد

• Biostatistics
• Clinical Trials
• Multivariate Analysis
• +۴ مورد دیگر

Vernon M. Chinchilli is a Distinguished Professor of Public Health Sciences and Professor of Statistics at The Pennsylvania State University. He holds appointments in the Department of Public Health Sciences (Division of Biostatistics and Bioinformatics) and the Department of Statistics. His primary affiliation is with the College of Medicine. Dr. Chinchilli received his PhD in Statistics from the University of North Carolina at Chapel Hill (1979) and a BS in Mathematics from Penn State (1974). His research focuses on biostatistical methodology for multi-center clinical trials, multivariate analysis of longitudinal data, and statistical methods for crossover designs. He has led NIH-funded Data Coordinating Centers for studies on lung disease, kidney disease, and acute kidney injury (AKI). Notable roles include Principal Investigator for the Natural History of AKI Consortium and the Biostatistics Research Center for Impaired Awareness of Hypoglycemia. Dr. Chinchilli teaches doctoral courses in multivariate analysis (PHS 523) and statistical methods in public health (PHS 554/555). He has advised 35 PhD and 40 MS students. His honors include Fellow of the American Statistical Association (1997) and extensive contributions to methodological advancements in clinical trial design and analysis. Key areas of investigation include: 1) statistical methods for agreement assessment and equivalence testing in clinical trials, 2) biomarker development for kidney function decline, and 3) application of machine learning in predicting post-hospitalization outcomes. He collaborates internationally on projects like the ENICTO cancer treatment outcomes initiative and the S-AKI sepsis biomarker study. Recent work explores: cognitive change measurement in aging populations, opioid alternative therapies for chronic pain, and vaccine efficacy in immunocompromised patients. His research spans 541 peer-reviewed publications and 15 active NIH grants, with particular emphasis on translating statistical innovations into clinical practice.

• Cardiovascular Imaging
• Molecular Imaging
• Translational Research
• +۵ مورد دیگر

Albert J. Sinusas, M.D., is a Professor of Medicine (Cardiovascular Medicine and Radiology & Biomedical Imaging) at Yale University School of Medicine and holds adjunct roles in Biomedical Engineering. He leads the Yale Translational Research Imaging Center (Y-TRIC) and directs Advanced Cardiovascular Imaging at Yale New Haven Hospital. His roles include Chairman of multiple committees (Yale Radioactive Drug Research Committee, Radiation Safety Committee) and Board Member of the Intersocietal Accreditation Commission (IAC) for Nuclear/PET imaging. Dr. Sinusas earned his MD from the University of Vermont and completed training in Internal Medicine at the University of Oklahoma and Cardiology/Nuclear Cardiology at the University of Virginia. His research focuses on cardiovascular imaging innovations, including molecular imaging of myocardial injury, angiogenesis, and peripheral artery disease. His translational work employs multidisciplinary modalities such as PET/CT, SPECT/CT, MRI, and echocardiography. He leads NIH-funded grants and trains researchers through a T32 grant. With over 250 peer-reviewed publications, he co-edited textbooks on cardiovascular molecular imaging and hybrid imaging in cardiovascular medicine. Key research interests include developing novel imaging tracers, AI-enhanced diagnostic tools, and non-invasive assessment of cardiovascular pathophysiology. Notable contributions include advancements in PET-derived myocardial blood flow quantification and SPECT imaging optimization using deep learning. Dr. Sinusas has received prestigious awards like the SNMMI Hermann Blumgart Award (2008) and is frequently recognized in 'Best Doctors in America.' He serves on editorial boards for Journal of Nuclear Medicine , Journal of Nuclear Cardiology , and JACC: Cardiovascular Imaging . His clinical expertise includes ECG, stress testing, and interpretation of SPECT/PET imaging studies. He oversees Y-TRIC’s mission to bridge preclinical and clinical imaging research, fostering collaboration across engineering, radiology, and cardiology.

• Cardiology
• Internal Medicine
• Hypertension Research
• +۴ مورد دیگر

Assoc. Prof. Dr. Erdoğan Sökmen serves as a full-time academician at Kırşehir Ahi Evran University Faculty of Medicine within the Department of Internal Medical Sciences . His clinical and research activities focus on cardiology, particularly coronary artery disease and electrophysiological assessments. His educational background includes a Medical Degree from Istanbul University Cerrahpasa Faculty of Medicine (2007) and Medical Specialization in Internal Medical Sciences from Health Sciences University (2012). He maintains professional certifications in Good Clinical Practices and holds advanced English proficiency (YDS 93). Dr. Sökmen's research centers on cardiovascular pathophysiology with emphasis on: Electrocardiographic parameters in myocardial infarction Inflammatory biomarkers in hypertension Coronary artery anomalies and reperfusion phenomena Metabolic interactions in cardiovascular disease His publication analysis reveals consistent contributions to understanding no-reflow phenomenon, ventricular repolarization abnormalities, and novel biomarkers like nesfatin-1 and omentin-1. He actively participates in academic service as a member of both the Turkish Cardiology Association and European Society of Cardiology since 2012. His mentorship includes supervising Samet Altunbaş's thesis on myocardial infarction biomarkers. With an h-index of 11 (UNIS) and 10 (WoS), his work demonstrates significant scholarly impact in cardiovascular medicine.

• Molecular Imaging
• Positron Emission Tomography (PET)
• Cancer
• +۴ مورد دیگر

Professor Andreas Kjær (MD, PhD, DMSc) serves as Head of the Cluster for Molecular Imaging (CMI) at the Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen. He is also Chief Physician at Rigshospitalet and co-founder of Minerva Imaging, a CRO established in 2011. University of Copenhagen Department of Biomedical Sciences Cluster for Molecular Imaging Rigshospitalet His research focuses on translational molecular imaging with PET/PET-MRI and targeted radionuclide therapies (theranostics) for precision medicine in cancer, cardiovascular, and inflammatory diseases. CMI bridges basic research to clinical implementation, leveraging interdisciplinary expertise in physics, chemistry, biology, and medicine to develop imaging agents and therapies. Recent publications highlight advancements in theranostics , PET/CT , hyperpolarized MRI , and radiopharmaceutical development . Collaborations span oncology, cardiology, and nuclear medicine, with clinical trials in neuroendocrine tumors and metabolic imaging. Current affiliations include University of Copenhagen (Professor, Department of Biomedical Sciences) Rigshospitalet (Chief Physician)

• Cardiovascular Imaging
• Translational Research
• Molecular Imaging
• +۹ مورد دیگر

Dr. Albert J. Sinusas is a Professor of Medicine (Cardiology) , Radiology & Biomedical Imaging , and Biomedical Engineering at Yale University . He serves as Director of the Yale Translational Research Imaging Center (Y-TRIC) and Advanced Cardiovascular Imaging at Yale New Haven Hospital. Education: BS from Rensselaer Polytechnic Institute (1979), MD from University of Vermont (1983), Internal Medicine training at University of Oklahoma (1986), Cardiology/Nuclear Cardiology at University of Virginia (1989) Dr. Sinusas specializes in non-invasive cardiovascular imaging with expertise in PET/CT, SPECT/CT, echocardiography, and MR imaging . His research focuses on molecular imaging of myocardial injury , angiogenesis , post-infarction remodeling , and deep learning applications in cardiac diagnostics. He has pioneered multimodality imaging approaches for cardiovascular pathophysiology assessment. Recent publications highlight his work in AI-driven cardiac imaging , novel PET tracers , and medical robotics . His team's 15 most recent articles (2024-2025) span topics from ARDS diagnostics to cardiovascular risk stratification using CT and PET technologies. Scientific Awards: SNMMI Hermann Blumgart Award (2008) Best Doctor in America (2001-2002, 2005-2015) M.A. Privatim from Yale (2006) Robert Wilkinson Lectureship (2014) Interurban Clinical Club membership (2017) As Principal Investigator on multiple NIH grants, Dr. Sinusas directs the NHLBI-funded T32 training program in multimodality cardiovascular imaging. His lab (Y-TRIC) houses state-of-the-art imaging resources including hybrid SPECT/CT , microCT , and 3D ultrasound systems for translational research from animal models to clinical applications.

• Cardiovascular Epidemiology
• Sex and Gender Differences in Cardiovascular Disease
• Comparative Effectiveness Research
• +۵ مورد دیگر

Louise Pilote, MD, MPH, PhD is Professor of Medicine in the Department of Medicine, Division of Internal Medicine , McGill University , and Senior Scientist in the Cardiovascular Health Across the Lifespan Program at the Research Institute of the McGill University Health Centre (RI-MUHC) , Montréal, Canada. Education: Louise Pilote holds the combined degrees of MD, MPH, and PhD, reflecting advanced clinical, public-health and research training that underpins her translational work. Research Focus: Internationally recognized pioneer in sex- and gender-based cardiovascular epidemiology , developing novel gender indices to disentangle biological (sex) and sociocultural (gender) determinants of cardiovascular outcomes. Leads the multinational GOING-FWD consortium (Gender Outcomes International Group to Further Well-being Development), integrating sex/gender analytics across 30 cohorts totaling 30 million patients with chronic diseases. Authority on comparative effectiveness and pharmacoepidemiology leveraging administrative “Big Data”, clinical registries, and advanced biostatistical/machine-learning methodologies. Current clinical-translational projects include imaging-based diagnosis of coronary microvascular dysfunction , a condition disproportionately affecting women. Scientific Impact & Awards: While formal awards are not enumerated in the supplied text, Dr Pilote’s sustained leadership as senior author on major Canadian and international cardiovascular guidelines, her role in founding the GOING-FWD network, and her extensive publication record (398 PubMed-indexed articles, 1988-2025) collectively constitute significant peer recognition. Students & Mentoring: Specific trainee names are not provided in the text; however, as Professor at McGill and Senior Scientist at RI-MUHC she supervises graduate students, clinical research fellows, and post-doctoral researchers in cardiovascular epidemiology, data science, and gender medicine. Laboratories & Teams: Dr Pilote heads the cardiovascular epidemiology research group within the Centre for Outcomes Research and Evaluation (CORE) at RI-MUHC, coordinating a multi-disciplinary team of biostatisticians, data scientists, clinician-scientists, and trainees.